PUBLICATION
Prostaglandin E2: Making More of Your Marrow
- Authors
- Lord, A.M., North, T.E., and Zon, L.I.
- ID
- ZDB-PUB-071219-13
- Date
- 2007
- Source
- Cell cycle (Georgetown, Tex.) 6(24): 3054-3057 (Review)
- Registered Authors
- Lord, Allegra, North, Trista, Zon, Leonard I.
- Keywords
- none
- MeSH Terms
-
- Animals
- Bone Marrow
- Dinoprostone/analogs & derivatives
- Dinoprostone/pharmacology
- Dinoprostone/physiology*
- Hematopoiesis/drug effects
- Hematopoiesis/physiology*
- Hematopoietic Stem Cell Transplantation/methods
- Hematopoietic Stem Cells/cytology
- Hematopoietic Stem Cells/drug effects
- Hematopoietic Stem Cells/physiology*
- Humans
- Mice
- Signal Transduction
- Zebrafish
- PubMed
- 18075310 Full text @ Cell Cycle
Citation
Lord, A.M., North, T.E., and Zon, L.I. (2007) Prostaglandin E2: Making More of Your Marrow. Cell cycle (Georgetown, Tex.). 6(24):3054-3057.
Abstract
We have recently demonstrated through a chemical screen in the zebrafish embryo that prostaglandin E2 (PGE2) is an evolutionarily conserved regulator of hematopoietic stem cell (HSC) number. These results have further been confirmed by in vitro and in vivo studies in the murine model. Bioactive PGE2 derivatives have potential clinical application to accelerate recovery of the hematopoietic system following chemotherapy or irradiation. Ex vivo expansion of HSCs prior to stem cell transplantation may improve reconstitution of hematopoiesis and immune function. This article aims to summarize current knowledge of PGE2-mediated regulation of blood cell homeostasis as well as to discuss the proposed use of PGE2 to expand hematopoietic stem cells for transplantation in the clinical setting.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping